Table 2.
Cox univariate and multivariate analysis for progression-free survival (PFS).
| Variables | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| HR (95% CI) | P-value | HR (95% CI) | P-value | |
| Age | 1.01 (1.00–1.03) | 0.008 | 1.00 (0.09–1.02) | 0.34 |
| LPS-PIV < 8/ ≥ 8 | 0.61 (0.46–0.81) | 0.001 | 0.98 (0.64–1.52) | 0.96 |
| BRCA status mut/wt | 0.43 (0.31–0.60) | 0.0001 | 0.50 (0.35–0.71) | 0.0001 |
| PDS/NACT | 0.61 (0.46–0.81) | 0.001 | 0.79 (0.52–1.20) | 0.27 |
| RT 0/ > 0 | 0.49 (0.33–0.71) | 0.0001 | 0.51 (0.35–0.75) | 0.001 |
| NLR ≤ 4/ > 4 | 0.69 (0.52–0.91) | 0.01 | 0.69 (0.51–0.95) | 0.023 |
LPS-PIV: laparoscopic predictive index value; mut: mutated; WT: wild type; PDS: primary debulking surgery; NACT: neoadjuvant chemotherapy; RT: residual tumor; NLR: neutrophil/lymphocyte ratio.